Evolent Health, Inc. (NYSE:EVH – Free Report) has earned a consensus rating of “Moderate Buy” from the ten analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year target price among analysts that […]
Evolent Health (NYSE:EVH – Free Report) had its price target trimmed by Guggenheim from $50.00 to $47.00 in a research report sent to investors on Monday, The Fly reports. A number of other analysts have also recently weighed in on the company. Stephens began coverage on Evolent Health in a research report on Tuesday, April […]
Moody National Bank Trust Division grew its position in Evolent Health, Inc. (NYSE:EVH – Free Report) by 51.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,262 shares of the technology company’s stock after acquiring an additional 21,256 shares during […]
Evolent Health (NYSE:EVH – Free Report) had its target price cut by Guggenheim from $50.00 to $47.00 in a research note released on Monday, The Fly reports. Several other equities analysts have also recently weighed in on the company. StockNews.com assumed coverage on Evolent Health in a report on Thursday, May 18th. They set a […]
Dakota Wealth Management increased its stake in Evolent Health, Inc. (NYSE:EVH – Free Report) by 7.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,781 shares of the technology company’s stock after purchasing an additional 512 shares during the quarter. Dakota Wealth Management’s […]